Stallergenes Greer in brief
Stallergenes Greer is a fully integrated global biopharmaceutical company specialising in the diagnosis and treatment of allergies through the research, the development and commercialisation of allergen immunotherapy (AIT) products and services.
Stallergenes Greer has an extensive global footprint, and the largest allergen and finished AIT product manufacturing capacity globally. The company’s extensive product portfolio, available in multiple formulations (subcutaneous, sublingual drops and tablets), offers patients innovative solutions to improve the life for people with allergies.
The company has around 1,100 employees in 19 countries, its distribution network is active in 41 countries.